AR064306A1 - Antagonistas del receptor de angiotensina ii - Google Patents

Antagonistas del receptor de angiotensina ii

Info

Publication number
AR064306A1
AR064306A1 ARP070105570A ARP070105570A AR064306A1 AR 064306 A1 AR064306 A1 AR 064306A1 AR P070105570 A ARP070105570 A AR P070105570A AR P070105570 A ARP070105570 A AR P070105570A AR 064306 A1 AR064306 A1 AR 064306A1
Authority
AR
Argentina
Prior art keywords
group
alkyl
angiotensin
hydrogen
receiver antagonists
Prior art date
Application number
ARP070105570A
Other languages
English (en)
Inventor
Silvia Stefanini
Nicoletta Almirante
Laura Storoni
Iyassu K Sebhat
Ravi P Argund
Amjad Ali
Chris Franklin
Lo Michael Man-Chu
Original Assignee
Merck & Co Inc
Nicox Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc, Nicox Sa filed Critical Merck & Co Inc
Publication of AR064306A1 publication Critical patent/AR064306A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/42—Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of mineralocorticosteroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Neurosurgery (AREA)
  • Endocrinology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Hospice & Palliative Care (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Vascular Medicine (AREA)
  • Psychiatry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Un compuesto para uso farmacéutico o uno de sus hidratos. Es util para el tratamiento de la hipertension. Reivindicacion 1: Un compuesto que tiene la formula general (1) donde R se selecciona del grupo que consiste en el grupo de formulas (2); Y es -Y1-Y2-Y3-Y4-Y5-; Y1 es C(R1R2); R1 se selecciona del grupo que consiste en hidrogeno y alquilo C1-4; R2 se selecciona del grupo que consiste en hidrogeno, alquilo C1-4 y -OC(O)alquiloC1-4; Y2 es O, C(O), P(O)(OH) o CH2; Y3 es O, C(O) o CH2, siempre que cuando Y2 es C(O), entonces Y3 no es C(O), y además, siempre que cuando Y2 es O, entonces Y3 no es O, y cuando Y2 es P(O)(OH), entonces Y3 es O; Y4 es O o CH2, o está ausente, siempre que cuando Y3 es O, entonces Y4 no es O; Y5 es - (CH2)1-2-(X)0-1-(CH2)0-1- o está ausente; X es -O- o -CR3R4-; y R3 y R4 se seleccionan de manera independiente del grupo que consiste en hidrogeno y alquilo C1-4 o una de sus sales aceptables para uso farmacéutico.
ARP070105570A 2006-12-13 2007-12-12 Antagonistas del receptor de angiotensina ii AR064306A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US87463006P 2006-12-13 2006-12-13

Publications (1)

Publication Number Publication Date
AR064306A1 true AR064306A1 (es) 2009-03-25

Family

ID=39536882

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP070105570A AR064306A1 (es) 2006-12-13 2007-12-12 Antagonistas del receptor de angiotensina ii

Country Status (18)

Country Link
US (2) US7880014B2 (es)
EP (1) EP2121665B1 (es)
JP (1) JP2010513274A (es)
KR (1) KR20090103916A (es)
CN (1) CN101547918A (es)
AR (1) AR064306A1 (es)
AU (1) AU2007334522B2 (es)
CA (1) CA2671673A1 (es)
CL (1) CL2007003613A1 (es)
DO (1) DOP2009000139A (es)
EA (1) EA200900808A1 (es)
MX (1) MX2009006210A (es)
NO (1) NO20092638L (es)
PE (1) PE20081382A1 (es)
TN (1) TN2009000236A1 (es)
TW (1) TW200831079A (es)
WO (2) WO2008076246A2 (es)
ZA (1) ZA200904479B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200831079A (en) * 2006-12-13 2008-08-01 Merck & Co Inc Angiotensin II receptor antagonists
AR069340A1 (es) * 2007-11-26 2010-01-13 Merck & Co Inc Antagonistas del receptor de angiotensina ii
CA2724919A1 (en) * 2008-06-09 2009-12-17 Nicox S.A. Angiotensin ii receptor antagonists
AR073259A1 (es) * 2008-07-29 2010-10-28 Merck & Co Inc Derivados de furosemida utiles como diureticos
AR074425A1 (es) 2008-12-05 2011-01-19 Merck Sharp & Dohme Derivados de nitrooxi como antagonistas del receptor de angiotensina ii.
JO3350B1 (ar) 2011-03-07 2019-03-13 Merck Sharp & Dohme مشتقات حلقية غير متجانسة محتوية على مجموعات أمينو أولية ومركبات داي أزينيومديولات
CN105218527B (zh) * 2015-10-10 2018-04-24 江苏宝众宝达药业有限公司 一种exp-3174的制备方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5138069A (en) * 1986-07-11 1992-08-11 E. I. Du Pont De Nemours And Company Angiotensin II receptor blocking imidazoles
IT1243367B (it) 1990-07-26 1994-06-10 Italfarmaco Spa Derivati acidi benzoici sostituiti ad attivita' cardiovascolare
IT1295694B1 (it) * 1996-11-14 1999-05-27 Nicox Sa Nitrossi derivati per la preparazione di medicamenti ad attivita antitrombinica
IT1311923B1 (it) 1999-04-13 2002-03-20 Nicox Sa Composti farmaceutici.
IT1311924B1 (it) 1999-04-13 2002-03-20 Nicox Sa Composti farmaceutici.
IT1314184B1 (it) 1999-08-12 2002-12-06 Nicox Sa Composizioni farmaceutiche per la terapia di condizioni di stressossidativo
EP1603933A2 (en) * 2003-03-13 2005-12-14 Nitromed, Inc. Nitrosated and nitrosylated compounds, compositions and methods of use
UA87983C2 (ru) * 2003-07-31 2009-09-10 Никокс С.А. Производные блокиратора рецептора ангиотензина ii
CA2536975A1 (en) * 2003-08-28 2005-03-17 Nitromed, Inc. Nitrosated and nitrosylated diuretic compounds, compositions and methods of use
CN1914149A (zh) * 2004-01-27 2007-02-14 默克弗罗斯特公司 用于治疗处于血栓形成心血管事件危险中的患者的环氧合酶－2为媒的疾病或状况的组合治疗
WO2006079610A1 (en) 2005-01-31 2006-08-03 Nicox S.A. Nitrooxy sartan derivatives as angiotensin ii receptor blockers for the treatment of cardiovascular and inflammatory diseases
WO2006091716A2 (en) * 2005-02-24 2006-08-31 Nitromed, Inc. Nitric oxide enhancing diuretic compounds, compositions and methods of use
WO2007019448A2 (en) * 2005-08-08 2007-02-15 Nitromed, Inc. Nitric oxide enhancing angiotensin ii antagonist compounds, compositions and methods of use
TW200831079A (en) * 2006-12-13 2008-08-01 Merck & Co Inc Angiotensin II receptor antagonists
AU2007334521B2 (en) * 2006-12-13 2012-03-29 Merck & Co., Inc. Angiotensin II receptor antagonists
AR069340A1 (es) * 2007-11-26 2010-01-13 Merck & Co Inc Antagonistas del receptor de angiotensina ii

Also Published As

Publication number Publication date
NO20092638L (no) 2009-09-11
WO2008076247A3 (en) 2009-01-15
PE20081382A1 (es) 2008-09-18
KR20090103916A (ko) 2009-10-01
EA200900808A1 (ru) 2009-12-30
ZA200904479B (en) 2010-09-29
EP2121665A2 (en) 2009-11-25
TN2009000236A1 (en) 2010-10-18
CN101547918A (zh) 2009-09-30
EP2121665B1 (en) 2014-01-22
AU2007334522B2 (en) 2012-03-15
WO2008076247A2 (en) 2008-06-26
JP2010513274A (ja) 2010-04-30
US7880014B2 (en) 2011-02-01
WO2008076246A2 (en) 2008-06-26
CA2671673A1 (en) 2008-06-26
AU2007334522A1 (en) 2008-06-26
CL2007003613A1 (es) 2008-07-11
US20100152259A1 (en) 2010-06-17
WO2008076246A3 (en) 2009-01-15
DOP2009000139A (es) 2009-08-31
TW200831079A (en) 2008-08-01
MX2009006210A (es) 2009-07-22
US20080194660A1 (en) 2008-08-14

Similar Documents

Publication Publication Date Title
AR064306A1 (es) Antagonistas del receptor de angiotensina ii
HRP20120323T1 (en) Diarylhydantoin compounds
RS52534B (en) MACROCYCLIC COMPOUNDS OF HINOXALINE AS HCV NS3 PROTEASE INHIBITORS
ZA201102735B (en) Antagonists of the vanilloid receptor subtype 1(vr1) and uses thereof
RS51943B (en) PIPERIDINSKI GPCR AGONIST
ES2531009T3 (es) Análogos sustituidos de dicetopiperazina para su uso como agentes para la administración de fármacos
DK2134691T3 (da) Quinolinonderivativer som parp- og tank-inhibitorer
DOP2010000226A (es) Compuestos triciclicos que tienen actividad antagonista de factor de liberacion de corticotropina y composiciones farmaceuticas que contienen los mismos
MX2009005462A (es) Analogos de 7,8-saturados-4,5-epoxi-morfinano.
SG163585A1 (en) Melanocortin receptor ligands
RS52881B (en) BENZAMIDINE COMPOUNDS USED AS HISTONAL DEACETYLASE INHIBITORS
RS52700B (en) SUBSTITUTED OXINDOL DERIVATIVE AND ITS USE AS A VASOPRESIN RECEPTOR LIGAND
BRPI0518581A2 (pt) compostos de cromanilurÉia que inibem o receptor do subtipo 1 do recepetor vanilàide (vr1) e usos destes
MX2009010552A (es) Antagonistas de receptor de opioide periferico y usos de los mismos.
EA200802380A1 (ru) Совместные кристаллы пирролидинонов
AR064521A1 (es) Activador de glucoquinasa
EA200700365A1 (ru) Производные индол-2-карбоксамидина как антагонисты nmda рецептора
DE602006012694D1 (de) Benzimidazolthiophenverbindungen als plk-modulatoren
RS52900B (en) Benzoylpyrazole Compound, Process for Production and Production of Herbicides Containing Them
EA201100612A1 (ru) Новые производные 2-амидотиадиазола
EA200970372A1 (ru) Ингибитор развития болезни альцгеймера, содержащий гетероциклическое соединение
AR060379A1 (es) Compuesto y composicion herbicida
EA200801549A1 (ru) Новые производные фенантридина в качестве антагонистов брадикинина
NO20084698L (no) Metode for fremstilling av indazolyl-ureaer som inhiberer vanilloidreseptor subtype 1(VR1)
HRP20090011T3 (en) 2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl-piperidines used as cgrp antagonists

Legal Events

Date Code Title Description
FB Suspension of granting procedure